Bleeding risk in thrombocytopenic patients after dental extractions: a retrospective single-center study

Sandhu, Sahil; Sankar, Vidya; Villa, Alessandro

doi:10.1016/j.oooo.2019.12.010

Cited by 4 publications

(3 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The studies included in the review were small cohort studies that were heterogenous. Another retrospective cohort study investigated bleeding complications in patients with mild to severe thrombocytopenia after extractions 101 . Over half of the patients displayed evidence of chronic periodontitis, although the reasons for the extractions were not specified.…”

Section: Prevention and Management Of Complications And Treatment Err...mentioning

confidence: 99%

“…Another retrospective cohort study F I G U R E 3 Multiple hematomas following scaling and root planing in a patient with liver cirrhosis. investigated bleeding complications in patients with mild to severe thrombocytopenia after extractions 101. Over half of the patients displayed evidence of chronic periodontitis, although the reasons for the extractions were not specified.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Complications and treatment errors in periodontal therapy in medically compromised patients

Leira

Marletta

Orlandi

et al. 2022

Periodontology 2000

View full text Add to dashboard Cite

In 2019, worldwide life expectancy was estimated at approximately 72 years of age. This has improved dramatically over decades, and is mirrored in childhood survival rates. 1 As a consequence, the number of people presenting with long-term conditions is increasing rapidly, as it is closely related to aging. 2 Multimorbidity in this aging population is common and it has been rising in prevalence over recent years, with one in three adults living with more than one chronic disease. 3,4 Evidence on the prevalence of systemic diseases in patients presenting for periodontal care suggests that between 40% and 52% of patients have more than one systemic condition, and these estimates increase with age. [5][6][7] In addition, the type of medical problems patients present with can differ significantly depending upon the facility where periodontal care is provided. 8 Findings from a retrospective analysis demonstrated a lower prevalence of medically compromised patients with periodontitis who attended a private dental practice (28%) compared with those attending a dental school or hospital clinic (46% and 74%, respectively). 8 Differences between participants in terms of age, socioeconomic status, or health awareness could explain these findings. 8 The most frequently reported medical problems in the dental office are allergies to medications followed by cardiovascular diseases (including hypertension) and endocrine disorders (including diabetes mellitus). [5][6][7][8][9][10] As a direct consequence of medical comorbidities, a substantial number of patients will be taking multiple medications, which may also have an impact on their periodontal management.Radfar and Suresh 11 observed that of 1041 patients treated in their dental school, 360 (35%) were taking antihypertensives, 202 (19%) painkillers, 181 (17%) antidepressants, 107 (10%) antidyslipidemic agents, and 95 (9%) antiplatelet drugs. This highlights an additional consideration in terms of the potential pharmacologic interactions with anesthetics or other medications that we might need to prescribe for these patients after certain periodontal procedures.In addition to the systemic pathology inherent to age and polypharmacy, the increased survival of patients with certain congenital diseases with periodontal manifestations has created a growing demand for periodontal treatment. These congenital disorders includeThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

show abstract

Section: Prevention and Management Of Complications And Treatment Err...mentioning

confidence: 99%

mentioning

confidence: 99%

Complications and treatment errors in periodontal therapy in medically compromised patients

Leira

Marletta

Orlandi

et al. 2022

Periodontology 2000

View full text Add to dashboard Cite

show abstract

“…Незважаючи на низку заходів щодо подолання стоматологічних кровотеч, відкритим залишається питання зупинки первинних та вторинних кровотеч різного ґенезу через ускладнення на фоні супутніх захворювань та паралельну фармакотерапію (здебільшого прийом антикоагулянтів). Цю проблему у своїх працях висвітлюють Леслі Р. Халперн, Девід Р. Адамс, Ерл Кларксон [8], Шайба Сандху, Алессандро Вілла [9], Мохаммед АльШиф, Дженні Грей, Абдул Салам Аль-Шаммарі [10], Озге Доганай, Белір Аталай [11], Райан Т. Рубіно, Дольф Р. Доусон, Річард Дж. Крісціо, Моханад Аль-Саббаг [12], М. Сюзен, Т. Девелі, С. Учан [13], Аманда Леал Роча, Сицилія Резенде Олівейра, Алессандра Фігейредо Соуза, Деніз Вієйра Травассос, Лукас Гімарайнш Абреу, Даніель Діас Рібейро, Тарсілія Апаресіда Сілва [14], А. Окерман, М. Борнштейн, Ю. Ю. Леунг, С. К. Лі, К. Політіс, Р. Джейкобс [15].…”

unclassified

The marketing study of the pharmaceutical market of Ukraine in the segment of antihemorrhagic agents to stop dental bleeding

Laba¹,

Azarenko²,

Євтушенко³

2021

Soc. pharm. health care

View full text Add to dashboard Cite

Aim. To conduct the marketing research of the Ukrainian market in the segment of antihemorrhagic agents used in dentistry.Materials and methods. The study was performed using the structural analysis, logical and graphical methods, marketing analysis methods.Results. The state of the Ukrainian market of drugs of this group has been determined. The market structure has been revealed in the number of names, brands, in forms of production, manufacturers, composition. Despite the sufficient number of registered drugs at the market (26 positions), a rather small arsenal of active substances (4) and dosage forms (3) can be observed. The market is characterized by a limited amount of drugs with a certain pharmacodynamics combining a rapid hemostatic effect, safety in use, the ability to suppress bacterial flora, and without the effect on healthy tissues. However, a positive moment should be noted: by the structure of manufacturer countries the market remains domestic (60 : 40).Conclusions. The Ukrainian pharmaceutical market is characterized by a sufficient assortment of hemostatic agents, but the use of these drugs in dentistry has its limitations. Dental doctors have certain problems with the occurrence of capillary bleeding and require a sufficient amount of effective and fastacting drugs for local application. Therefore, the search and creation of new drugs with a similar action at this stage remains a relevant scientific issue.

show abstract

Thrombocytopenia

2022

A Practical Approach to Special Care in Dentistry

View full text Add to dashboard Cite

Bleeding risk in thrombocytopenic patients after dental extractions: a retrospective single-center study

Cited by 4 publications

References 19 publications

Complications and treatment errors in periodontal therapy in medically compromised patients

Complications and treatment errors in periodontal therapy in medically compromised patients

The marketing study of the pharmaceutical market of Ukraine in the segment of antihemorrhagic agents to stop dental bleeding

Thrombocytopenia

Contact Info

Product

Resources

About